| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 7 | |
| #2 | WIPO (World Intellectual Property Organization) | 6 | |
| #3 | Australia | 3 | |
| #4 | Canada | 3 | |
| #5 | China | 3 | |
| #6 | EPO (European Patent Office) | 3 | |
| #7 | Taiwan | 3 | |
| #8 | Argentina | 1 | |
| #9 | Israel | 1 | |
| #10 | New Zealand | 1 | |
| #11 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Liu Fang-Yu | 21 |
| #2 | Liu Fangyu | 9 |
| #3 | Shen Zhiqun | 8 |
| #4 | Shen Zhi-Qun | 7 |
| #5 | He Min Michael | 7 |
| #6 | Lin Chi-Cheng | 6 |
| #7 | Zhang Yu | 6 |
| #8 | Fu Enjun | 6 |
| #9 | Yang Chin-Yao | 6 |
| #10 | Qiao Li | 5 |
| Publication | Filing date | Title |
|---|---|---|
| TW202015686A | Kinase inhibitor salts and compositions thereof | |
| US10098898B1 | Release stable mesalamine dosage forms | |
| US2016206557A1 | Stable solid fingolimod dosage forms | |
| AU2016209466A1 | Stable solid fingolimod dosage forms | |
| WO2013110085A1 | Oral dosage forms for delivering metformin and sitagliptin | |
| WO2013077847A1 | Oral dosage forms for delivering gabapentin | |
| CN105343885A | Oral formulation for dexlansoprazole |